Prior to Dewpoint, Geoff held several leadership roles in support of multiple therapeutic areas over a span of 13 years at Bristol Myers Squibb. His teams drove commercial assessments and performance analyses of marketed products, leveraged analytics to optimize R&D portfolio investments, developed topline estimates in support of long-term financial planning, and conducted commercial assessments in support of business development.
Prior to Bristol Myers Squibb, Geoff was a discovery scientist at Abbott Laboratories engaged in structure-based drug design. He later moved to the decision analysis group where he conducted asset valuation analyses in support of R&D portfolio investment decisions.
Geoff is a veteran and Lieutenant Colonel (retired) in the United States Army Reserve where he served for over 24 years. He holds a Bachelor of Science degree in Biochemistry from the University of Missouri, a Ph.D. in Biophysics from Brandeis University, and was a postdoctoral fellow in the Department of Chemistry at the Massachusetts Institute of Technology.